Literature DB >> 231819

Angiotensin converting enzyme. III. Changes in serum level as an indicator of disease activity in untreated sarcoidosis.

O Selroos, C Grönhagen-Riska.   

Abstract

The activity of serum angiotensin converting enzyme (ACE) was repeatedly measured together with serum lysozyme (LZM) in patients with untreated sarcoidosis. Changes in the clinical picture were registered using chest X-ray, forced vital capacity (FVC), diffusing capacity for carbon monoxide (DLCO) and appearance of extrapulmonary lesions. During a clinically unchanged period the highest ACE activity and the corresponding LZM value (not the highest value) were used for the calculation. A statistically significant change in ACE was noted when a normal chest X-ray changed to a stage II lesion or vice versa, and when a signficant change in FVC occurred. All other changes were insignificant. On the other hand, statistically significant changes in ACE were found during stable periods according to chest X-ray, FVC or DLCO. ACE is frequently elevated in serum of patients with active sarcoidosis. The fluctuations in activity mostly parallel the clinical course of the disease. The behaviour and metabolism of the enzyme need further investigation. An increased concentration of serum LZM is frequent in patients with active sarcoidosis. The highest LZM values are not always seen simultaneously with the highest ACE values, indicating that they probably express different dimensions of the disturbances in the sarcoid granuloma.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 231819

Source DB:  PubMed          Journal:  Scand J Respir Dis        ISSN: 0036-5572


  5 in total

Review 1.  Serum angiotensin converting enzyme in pulmonary disease.

Authors:  P K Rohatgi
Journal:  Lung       Date:  1982       Impact factor: 2.584

2.  Serum angiotensin converting enzyme in pneumonias.

Authors:  Y Kerttula; T H Weber
Journal:  J Clin Pathol       Date:  1986-11       Impact factor: 3.411

Review 3.  Angiotensin-converting enzyme and its clinical significance--a review.

Authors:  P R Studdy; R Lapworth; R Bird
Journal:  J Clin Pathol       Date:  1983-08       Impact factor: 3.411

Review 4.  Assessment of cardiac sarcoidosis with advanced imaging modalities.

Authors:  Makoto Orii; Toshio Imanishi; Takashi Akasaka
Journal:  Biomed Res Int       Date:  2014-08-28       Impact factor: 3.411

Review 5.  Catch the rainbow: Prognostic factor of sarcoidosis.

Authors:  Senol Kobak
Journal:  Lung India       Date:  2020 Sep-Oct
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.